Results 1 to 10 of about 57,355 (265)

Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasms [PDF]

open access: yesCancer, 1981
Antiserum to a human prostate-specific antigen was raised in a rabbit and utilized by immunoperoxidase staining to evaluate its potential value as a diagnostic histologic marker for tumors of prostatic origin. All primary and metastatic prostatic malignancies reacted positively, whereas nonprostatic neoplasms did not stain with this procedure.
T. Ming Chu   +13 more
openaire   +3 more sources

Studies on the clinical significance of nonesterified and total cholesterol in urine [PDF]

open access: yes, 1981
Gas-liquid chromatographic determinations of nonesterified and total urinary cholesterol were performed in 137 normals, 264 patients with various internal diseases without evidence of neoplasias or diseases of the kidney or urinary tract, 497 patients ...
A. Pickel   +35 more
core   +2 more sources

A novel combination of triple metachronous malignancies of the kidney, oropharynx and prostate. A case report [PDF]

open access: yes, 2015
Synchronous or metachronous malignancies are a rare event, with an incidence rate that increases with age. The present study reports the case of a 70-year-old Caucasian male who was referred to the outpatient office of the Urology Unit, Sapienza ...
Carbone, Antonio   +6 more
core   +1 more source

Incidental Lymphoplasmacytic Lymphoma Diagnosed Following Robotic-Assisted Laparoscopic Prostatectomy for Prostate Cancer [PDF]

open access: yes, 2019
© 2019 The Author(s). This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
Agarwal, Samita   +5 more
core   +1 more source

Surgery of bladder and prostatic neoplasms in children [PDF]

open access: yesCancer, 1973
Rhabdomyosarcoma is the common malignant soft tissue tumor of childhood. Twelve of 67 cases recently reviewed from this institution arose in the bladder or prostate (6 are surviving). Until recently and regardless of the primary site, the reports of successful treatment of this aggressive embryonal neoplasm have been limited to very small series or to ...
Victor Braren   +2 more
openaire   +2 more sources

Urinary cholesterol in cancer screening [PDF]

open access: yes, 1982
Cholesterol determinations in morning urine samples were taken in 235 selected patients with a positive test for microscopic hematuria. Values ranged from 0.2 to 76.0 mg (median 5.5) in 23 patients with urologic malignancies and from 0.1 to 33.4 mg ...
Acevedo   +16 more
core   +1 more source

miRegulome: a knowledge-base of miRNA regulomics and analysis [PDF]

open access: yes, 2015
miRNAs regulate post transcriptional gene expression by targeting multiple mRNAs and hence can modulate multiple signalling pathways, biological processes, and patho-physiologies.
Azevedo, Vasco   +13 more
core   +3 more sources

The human gastrointestinal microbiota and prostate cancer development and treatment [PDF]

open access: yes, 2020
The human gastrointestinal microbiome contains commensal bacteria and other microbiota that have been gaining increasing attention in the context of cancer development and response to treatment.
Alanee   +70 more
core   +1 more source

P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer. [PDF]

open access: yes, 1996
Mutations in the p53 tumour-suppressor gene are among the most common genetic alterations in human cancers. In the present study we analysed the mutations in the p53 tumor-suppressor gene in 25 primary and 20 metastatic human prostate cancer specimens ...
Chen, KM   +5 more
core   +2 more sources

Large-scale analysis of disease pathways in the human interactome

open access: yes, 2017
Discovering disease pathways, which can be defined as sets of proteins associated with a given disease, is an important problem that has the potential to provide clinically actionable insights for disease diagnosis, prognosis, and treatment ...
Agrawal, Monica   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy